Nephrocalcinosis fortuitously discovered: the role of surreptitious self administration of diuretics.

Furosemide Hypokalemia Nephrocalcinosis

Journal

Caspian journal of internal medicine
ISSN: 2008-6164
Titre abrégé: Caspian J Intern Med
Pays: Iran
ID NLM: 101523876

Informations de publication

Date de publication:
2024
Historique:
received: 18 10 2022
revised: 29 01 2023
accepted: 11 04 2023
medline: 11 3 2024
pubmed: 11 3 2024
entrez: 11 3 2024
Statut: ppublish

Résumé

Furosemide is a drug widely used for several medical conditions and could be used without medical prescription. Furosemide-related nephrocalcinosis can occur regardless of age, although the risk is higher in premature infants. The defining characteristic of nephrocalcinosis is generalized calcium deposition in the kidney. The most useful imaging studies for evaluation are ultrasonography and computed tomography (more effective in detecting calcification). A 32-year-old woman with a history of depressive syndrome was admitted for evaluation of fortuitously discovered nephrocalcinosis and hypokalemia. The studies performed revealed the presence of a metabolic alkalosis with discrete hyperreninism/hyperaldosteronism but normal ratio, normotension and urinary study showed elevated sodium, chloride, potassium and calcium fluctuating in different determinations. Surreptitious diuretic intake was suspected and urine analysis revealed doses equivalent to 80-120 mg. The patient was advised to discontinue all diuretic treatment; she was adequately supplemented with potassium and she was followed-up in outpatient clinics. During the follow-up, clinical and analytical improvement was noted, which led to the discontinuation of supplementation. Surreptitious diuretic intake is a clinical condition to rule out in patients with chronic hypokalemia, metabolic alkalosis with elevated urinary sodium and chloride. The relation between surreptitious diuretic intake and nephrocalcinosis has not been fully elucidated in adults.

Sections du résumé

Background UNASSIGNED
Furosemide is a drug widely used for several medical conditions and could be used without medical prescription. Furosemide-related nephrocalcinosis can occur regardless of age, although the risk is higher in premature infants. The defining characteristic of nephrocalcinosis is generalized calcium deposition in the kidney. The most useful imaging studies for evaluation are ultrasonography and computed tomography (more effective in detecting calcification).
Case Presentation UNASSIGNED
A 32-year-old woman with a history of depressive syndrome was admitted for evaluation of fortuitously discovered nephrocalcinosis and hypokalemia. The studies performed revealed the presence of a metabolic alkalosis with discrete hyperreninism/hyperaldosteronism but normal ratio, normotension and urinary study showed elevated sodium, chloride, potassium and calcium fluctuating in different determinations. Surreptitious diuretic intake was suspected and urine analysis revealed doses equivalent to 80-120 mg. The patient was advised to discontinue all diuretic treatment; she was adequately supplemented with potassium and she was followed-up in outpatient clinics. During the follow-up, clinical and analytical improvement was noted, which led to the discontinuation of supplementation.
Conclusion UNASSIGNED
Surreptitious diuretic intake is a clinical condition to rule out in patients with chronic hypokalemia, metabolic alkalosis with elevated urinary sodium and chloride. The relation between surreptitious diuretic intake and nephrocalcinosis has not been fully elucidated in adults.

Identifiants

pubmed: 38463929
doi: 10.22088/cjim.15.1.22
pmc: PMC10921103
doi:

Types de publication

Case Reports

Langues

eng

Pagination

184-187

Informations de copyright

© The Author(s).

Déclaration de conflit d'intérêts

The authors declared no conflicts of interest.

Auteurs

Nery Sablón-González (N)

Department of Nephrology, Dr Negrin University Hospital, Gran Canaria, Spain.

Liliana Morán-Calcedo (L)

Department of Nephrology, University Hospital del Tajo, Madrid, Spain.

Maria Belen Alonso-Ortiz (MB)

Department of Internal Medicine, Dr Negrin University Hospital, Gran Canaria, Spain.

Yanet Parodis-López (Y)

Avericum Hemodyalisis Center, Chiclana de la Frontera, Spain.

Angelica Laurin (A)

Barriom Atlantico Primary Care Center, Las Palmas, Spain.

Emmanuel Andrès (E)

Department of Internal Medicine, Strasbourg University Hospital, Strasbourg, France.

Noel Lorenzo-Villalba (N)

Department of Internal Medicine, Strasbourg University Hospital, Strasbourg, France.

Classifications MeSH